Executive Vice President and Chief Financial Officer
Intellia Therapeutics is a leading gene-editing company focused on the development of curative medicines using CRISPR/Cas9 technology
Graeme Bell is EVP & CFO at Intellia Therapeutics, a leading genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9 technology.Graeme has more than 20 years of experience in financial control and stewardship, financial planning and analysis, and management accounting. Over and above this, he has developed and led a best-in-class investor relations team, and has held international several positions in the U.S. and Europe, including CFO of Anacor, and Country CFO of Merck’s US and UK businesses. In addition to the pharmaceutical industry, Graeme has experience of other sectors, including brewing, textiles and printing. He has an MBA from Durham University in the UK, and is a Fellow of the Chartered Institute of Management Accountants (CIMA).
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Graeme Bell at Intellia Therapeutics then you’ve come to the right place.
Wondering if it's graeme@intelliatx.com, graeme.bell@intelliatx.com, bell@intelliatx.com, or gbell@intelliatx.com? We have the answers for you.